To: Director General of Royal Hospital, Director General of Khou la Hospital, Director General of Medical Supplies (MOH), Director General of Pvt. Health Est. Affairs (to kindly arrange distribution to all Pvt. Health Institutions), Director General of Health Services in all Governorates, Director of Rational Use of Medicine (MOH), Hospital Director (Al Nahda Hospital), Hospital Director (Al Massara Hospital), The Head of Medical Services in SQU Hospital, The Head of Medical Services in Royal Oman Police, The Head of Medical Services in Ministry of Defence, The Head of Medical Services in The Diwan, The Head of Medical Services in The Sultan's Special Force, The Head of Medical Services in Internal Security Services, The Head of Medical Services in Petroleum, The Head of Medical Services in LNG Oman, Director of Pharmacy & Medical Stores in all Governorate (for distribution pls), Marketing Authorization Holders & Pharmaceutical Companies, and All Private Pharmacies & Drug Stores

Subject: Regarding Product Recall (Class III) of All Batches of Rabezole 20MG E/C Tablets from Jamjoom Pharmaceuticals, Saudi Arabia

After Compliments,